Isoptin (Verapamil Hydrochloride)

Verapamil hydrochloride blocks L‑type calcium channels in cardiac muscle and vascular smooth muscle. By reducing calcium entry, it decreases myocardial contractility, slows atrioventricular nodal conduction, and causes peripheral vasodilation, which together lower blood pressure and reduce cardiac workload.

The appropriate dose of Isoptin is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Dosage may be adjusted over time to achieve optimal blood pressure control or symptom relief.

The safety of Isoptin in pregnancy or while breastfeeding has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To order Isoptin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Isoptin (verapamil) is a non‑dihydropyridine calcium channel blocker, primarily affecting cardiac conduction and contractility, whereas dihydropyridine agents like amlodipine mainly cause vascular smooth‑muscle relaxation. Verapamil is often chosen when rate control in arrhythmias is needed, while other agents may be preferred for isolated hypertension.

Isoptin should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain stability and potency.

Isoptin is taken orally, usually as a tablet, with or without food as directed by the prescriber. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without consultation.

Serious risks include marked bradycardia, severe hypotension, and heart block, which can lead to syncope or cardiac arrest. Patients should be monitored for these events, especially when initiating therapy or when combined with other agents that affect heart rate or blood pressure.

Isoptin is contraindicated in patients with known hypersensitivity to verapamil or any component of the formulation, in those with severe hypotension, advanced heart block without a pacemaker, and in individuals with certain types of heart failure where reduced contractility could be harmful.